Greatly Extended Subzero Ischemic Storage of Renal Allografts Using Novel Bio-inspired Next Generation Cryoprotectants

使用新型仿生下一代冷冻保护剂大大延长肾同种异体移植物的零度以下缺血储存

基本信息

  • 批准号:
    10761617
  • 负责人:
  • 金额:
    $ 97.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-01 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

Abstract: Organ preservation remains a daunting challenge. Organ specific ischemia windows of 4-24h greatly limit the field of organ transplantation to save lives and cause severe geographic restriction in the US and globally. However, by halting ischemic damage at the point of procurement, we could facilitate enhanced graft viability and thus faster patient recovery, drastically shorter hospital stays, and greatly diminished healthcare costs – all while tackling the biggest challenge of all – to increase the amount of available organs for transplant. The goal of this Direct-to-PhaseII SBIR proposal is to establish the pre-clinical use of XT-ViVo for the non- frozen, subzero ischemic preservation and transplantation of renal allografts leading to improved outcome in comparison to static cold storage and to render greatly extended CIT of up to 120h possible using practical storage and transport methods. Reducing damage during extended ischemia is of critical relevance to kidney transplantation. Indeed, the FDA has recognized this technology as a Breakthrough Device for up to 120h preservation of the kidney, which could lead to dynamic shifts to logistics of kidney transplantation. This project combines novel chemistry and expertise in tissue and organ preservation with world leaders in transplantation. We will apply novel cryoprotectants to high subzero temperature ischemic preservation of porcine kidneys followed by subsequent transplantation in an effort to significantly extend the ischemia window of human-sized organs in a clinically relevant model. The evaluation of innovative modalities that may transform current preservation strategies requires the use of translational animal models for reliable assessment of tissue viability and functional recovery post-preservation. Herein, we propose two primary aims of the proposed work. Advanced cryoprotectants will be synthesized and prepared into formulations as organ preservation solutions. The novel cryoprotectants will first be applied to the preservation of pig kidneys ex vivo, at subzero temperature. We will assess kidney survival, function, injury biomarkers, histology, and immunohistochemistry. This work will further asses the ability to greatly extend subzero ischemia time of the kidney up to 120h first ex vivo, and then using a widely-accepted preclinical large animal transplantation model for close clinical relevance to humans. Heterotopic kidney transplantation will be investigated after greatly extended ischemic storage on SLA-defined miniature swine. Animal survival and kidney function will be assessed similarly with a heightened level of detail at post-operative day 0, 1, 7, and 30 to assess both intermediate and long-term kidney function. Execution of the stated aims could result in a fundamental improvement in the field of organ transplantation and will aid acquisition of the final data set required prior to clearance and clinical for commercialization. The product will offer extension of the ischemia window, simplified use with minimal disruption of current practice, and strong cost competitiveness compared to the advanced organ perfusion systems being developed in the market today.
翻译后摘要:器官保存仍然是一个艰巨的挑战。器官特异性缺血时间窗4 - 24h, 限制器官移植领域以挽救生命,并在美国造成严重的地理限制, 在全球然而,通过在获取点停止缺血性损伤,我们可以促进增强移植物 生存能力,从而更快的病人恢复,大大缩短住院时间,大大减少医疗保健 成本--同时应对最大的挑战--增加可供移植的器官数量。 本直接进入II期SBIR提案的目标是确定XT-ViVo在非临床研究中的临床前使用。 冷冻、低温缺血保存和移植同种异体肾移植,改善了 与静态冷藏相比,使用实际的冷藏设备, 储存和运输方法。减少长期缺血期间的损伤对肾脏至关重要 移植事实上,FDA已将该技术视为突破性设备长达120小时 肾脏的保存,这可能导致肾脏移植物流的动态转变。 该项目将组织和器官保存方面的新颖化学和专业知识与世界领先的 移植我们将应用新型的冷冻保护剂进行高低温缺血保存, 猪肾,随后进行移植,以显著延长缺血窗口 人体大小的器官在一个临床相关的模型。对可能改变 目前的保存策略需要使用平移动物模型来可靠地评估组织 保存后的活力和功能恢复。在此,我们提出了拟议工作的两个主要目标。 先进的冷冻保护剂将被合成并制成制剂作为器官保存溶液。 新型冷冻保护剂将首先应用于在零度以下温度下离体保存猪肾。 我们将评估肾脏存活率、功能、损伤生物标志物、组织学和免疫组织化学。这项工作将 进一步评估了将肾脏的零下缺血时间大大延长至120小时的能力,首先离体,然后 使用广泛接受的临床前大型动物移植模型,与人类临床密切相关。 将研究在SLA定义的极大延长缺血储存后的异位肾移植。 迷你猪将以类似方式评估动物存活率和肾功能,并提高详细程度 在术后第0、1、7和30天评估中期和长期肾功能。 实现上述目标可能会导致器官移植领域的根本性改善, 将有助于在批准和商业化临床之前获得所需的最终数据集。产品 将提供缺血窗口的扩展,简化使用,最大限度地减少对当前实践的干扰, 与当今市场上正在开发的先进器官灌注系统相比,具有成本竞争力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gerald Brandacher其他文献

Gerald Brandacher的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gerald Brandacher', 18)}}的其他基金

New approaches to kidney banking through nature-inspired high sub-zero preservation strategies
通过受自然启发的高零度保存策略实现肾银行新方法
  • 批准号:
    10823132
  • 财政年份:
    2019
  • 资助金额:
    $ 97.12万
  • 项目类别:
Isochoric Pressure Based Preservation of Cells, Tissues and Organs
基于等容压的细胞、组织和器官保存
  • 批准号:
    9910362
  • 财政年份:
    2016
  • 资助金额:
    $ 97.12万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 97.12万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 97.12万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.12万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 97.12万
  • 项目类别:
    Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
  • 批准号:
    2889694
  • 财政年份:
    2023
  • 资助金额:
    $ 97.12万
  • 项目类别:
    Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 97.12万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 97.12万
  • 项目类别:
    Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 97.12万
  • 项目类别:
    Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 97.12万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 97.12万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了